The benefit of a neoadjuvant instillation of chemotherapy in non-muscle invasive bladder cancer: Interim analysis of the PRECAVE randomized clinical trial

Article

Abstract: Introduction: Although an immediate postoperative instillation of chemotherapy (IPOIC) after transur

Palabras claves:

Bladder carcinoma, Intravesical chemotherapy, Mitomycin C, Neoadjuvant, Recurrence, Urotelial carcinoma

Autores:

Alvarez-Maestro M., Bazán A.A., Diego M. Carrión, Martinez-Piñéiro L., Rios González E., Rivas J.G., Ruiz C.B.

Fuentes:

scopus